Carl L. Gordon, Director, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 80,934 shares at $10.06 ($796K) on 2022-01-12, disclosed to the SEC on 2022-01-13.
Open-market purchase of $796k THRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.81 | 1,600 | $16K | 2.0% |
| 2 | $10.67 | 6,900 | $74K | 9.2% |
| 3 | $10.06 | 18,897 | $190K | 23.9% |
| 4 | $10.06 | 18,897 | $190K | 23.9% |
| 5 | $9.43 | 17,320 | $163K | 20.5% |
| 6 | $9.43 | 17,320 |
| $163K |
| 20.5% |
| Total | $9.84 avg | 80,934 | $796K | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |